Lin Shen - Researcher Profile | RDL Research Database

Publications

3 shown

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang , Eric Van Cutsem , A. Feyereislova +13 more

2010 The Lancet 7049 citations

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Takashi Kojima , Manish A. Shah , Kei Muro +24 more

PURPOSE Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy. PATIENTS AND METHODS In this open-label, phas...

2020 Journal of Clinical Oncology 1110 citations

Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells

Zhiwei Zhou , Huabin He , Kun Wang +12 more

Granzyme A lights a fire Cytotoxic T cells and natural killer cells use several strategies to kill infected or transformed cells. One such pathway entails the delivery of a fami...

2020 Science 1217 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 9,376
Institution: Peking University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8798-4756

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.